Antiretrovirals Flashcards
NRTI’s
Zidovudine, Zalcitabine, Diadanosine, Stavudine, Abacavir, tenofovir, Lamivudien, emcitabine
NRTI’s MOA
substrate for RT, lack 3’OH group can’t elongate RNA
NRTI’s- what cells does it work in
Newly infected cells
NRTI- HIV1, 2 or both
Both
What is given to mother to prevent spread of HIV during child birth
NRIT
NRTI- AE
Lactic Acidosis (mtDNA interference), hepatic steatosis, N/V/D, fatigue, insomnia drugs with a d cause reversible, dose dependent peripheral neuropath
Zidovudine- abrev
AZT
Zidovudine- AE
Bone marrow suppression, malaise, myopathies, N/V, HA
Zidovudine- Contraindications
Don’t give to people with Ganciclovir, used to tx CMV
Zalcitabine- abrev
ddC
Zalcitabine- AE
peripheral neuropathy, pancreatitis
Didanosine- Abrev
ddl
Didanosine- AE
Pancreatitis- deadly Peripheral neuritis is common
Didanosine- meals
Do not take with meals, acid will destroy the drug
Stavudine- Abrev
d4t
Stavudine- AE
lipodystrophy- prevrent with pravastatin and atrovastatin peripheral nueropathy
Abacavir- abrev
ABC
Abacavir- AE
hypersensitivity rxn- deadly
Tenofovir- AE
nephrotoxic
Lamivudine, emtricitabine- AE
minimal toxicity, GI, HA
Emtricitabine- abrev
FTC
NRTI- MOR
3-4 AA mutations
NNRTI’s
Nevirapine, delavirdine, enfavirenz, etravirine, rilpirivine
NNRTI- MOA
non competitive antagonist of RT
NNRTI- new or old cells?
New
NNRTI- HIV1, 2, or both
HIV 1
NNRTI- AE
Rash, hepatotoxicity
NNRTI- MOR
1 codon change- very common
NNRTI- T1/2
long
NNRTI- protein binding
high
NNRTI- metabolism
in the liver and high
Nevirapine- effect on CYP450
Inducer
Delvaridine- effect on CYP450
Inhibitor
Efavirenz- AE
Abnormal CNS effects- vivid dreams, insomnia, dizziness
Effavirenz- Food
don’t take with fatty meals
Efavirenz- Contraindications
Pregnancy
Etravirine- - use
last line, NNRTI is have developed resistance to all the others
Riplirivine- AE
Severe rash, GI
Protease inhibitors
Indinavir, atazanavir, tipranavir, fosamprenavir, lopinavir, nelfinavir, ritonavir, saquinavir
PI- MOA
binds to active site of protease –> cant cleave the polyprotein
PI- new, old, both
both
PI- AE
hyperglycemia, dyslipidemia, lipodystrophy, osteoperosis, GI disturbances, redistribution of fat from face and extremities to waist
PI- resistance
4-5 Codon mutation
PI- lymphodystrophy
redistribution of fat from face and extremities to waist, HIV lymphodystrophy syndrome. Tx atrovastatin, provastatin
PI- liver enzymes
inhibitors or CYP3A4 –> lots of drug interactions
PI- metabolism
hepatic
PI- protein binding
high
PI- excretion
renal
PI- order of CYP3A4 interactions
Ritonavir- greatest squinavir- least
Indinavir- AE
Kidney stones, hyperbillirubinemia, alopecia
Atazanavir- AE
prolonged PR- messes up atria hyperbiirubinemia
Tipranavir-AE
Intracranial hemorrhage
Ritonavir- AE
largest inhibitor of CYP3A4 enzyme –> inhibits metabolism of other HIV drugs, so saves $
Fusion inhibitor
Enfuviritide- Fuzeon
Enfuviritide- MOA
binds to gp41 env protein and prevents fusion of HIV to cell
Enfuviritide- resistance
1 codon change, low barrier
Enfuviritide- HIV1,2, both
HIV1
Enfuviritide- usees
last ditch when all other drugs have failed
Enfuviritide- AE
Injection site rxns, N/D, fatigue, Neutropenia
Enfuviritide- admin
subcutaneous injection
Enfuviritide- protein binding
92%
Enfuviritide- metabolism
Proteloytic degridation, not hepatic metabolism
Agents for MDR HIV
Maraviroc, Raltegavir, Etravirine
Maraviroc- MOA
binds to CCR5, CCR5 antagonists, HIV can’t bind
Maraviroc- AE
Major hepatotoxicity
Raltegavir- MOA
integrase inhibitor
Etravirine- uses
really an NNRTI that is used when other drugs have failed